SCHEMBL4808693

SCHEMBL4808693

O=C1NC[C@@H]2CC[C@H]1N2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL399402 1.00
Hydrochloric Acid SCHEMBL30048867 0.98 CHRNB2 (0.32)
SCHEMBL31341750 0.80
SCHEMBL31390576 0.71
Hydrochloric Acid SCHEMBL31629822 0.70 CHRNB2 (0.30)
SCHEMBL31563715 0.69
SCHEMBL24616546 0.65
Hydrochloric Acid SCHEMBL32664168 0.63
SCHEMBL31390574 0.61 CHRNB2 (0.31)
SCHEMBL31390590 0.61 CHRNB2 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018011160-A1 6,7-DIHYDRO-4H-PYRAZOLO[1,5-A]PYRAZINE COMPOUNDS FOR THE TREATMENT OF INFECTIOUS DISEASES F. HOFFMANN-LA ROCHE AG (CH) 2018-01-18 WO disclosed
US-7468375-B2 Inhibitors of the HIV integrase enzyme PFIZER INC. (US) 2008-12-23 US disclosed
US-20050277662-A1 Inhibitors of the HIV integrase enzyme AGOURON PHARMACEUTICALS, INC 2005-12-15 US disclosed